Establishment and characterization of a novel treatment‐related neuroendocrine prostate cancer cell line KUCaP13

The prevalence of neuroendocrine prostate cancer (NEPC) arising from adenocarcinoma (AC) upon potent androgen receptor (AR) pathway inhibition is increasing. Deeper understanding of NEPC biology and development of novel therapeutic agents are needed. However, research is hindered by the paucity of r...

Descripción completa

Detalles Bibliográficos
Autores principales: Okasho, Kosuke, Mizuno, Kei, Fukui, Tomohiro, Lin, Yen‐Yi, Kamiyama, Yuki, Sunada, Takuro, Li, Xin, Kimura, Hiroko, Sumiyoshi, Takayuki, Goto, Takayuki, Kobayashi, Takashi, Lin, Dong, Wang, Yuzhuo, Collins, Colin C., Inoue, Takahiro, Ogawa, Osamu, Akamatsu, Shusuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253279/
https://www.ncbi.nlm.nih.gov/pubmed/33960594
http://dx.doi.org/10.1111/cas.14935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253279/
https://www.ncbi.nlm.nih.gov/pubmed/33960594
http://dx.doi.org/10.1111/cas.14935

Ejemplares similares